MOREPEN LABORATORIES
Back to Balance Sheet
|
MOREPEN LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹18 Cr | ₹9.76 Cr | ₹6.66 Cr | ₹2.64 Cr | ₹0.93 Cr |
What is the latest Contingent Liabilities ratio of MOREPEN LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹18 Cr |
| Mar2024 | ₹9.76 Cr |
| Mar2023 | ₹6.66 Cr |
| Mar2022 | ₹2.64 Cr |
| Mar2021 | ₹0.93 Cr |
How is Contingent Liabilities of MOREPEN LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹18 Cr | 87.61 | |
| Mar2024 | ₹9.76 Cr | 46.52 | |
| Mar2023 | ₹6.66 Cr | 152.33 | |
| Mar2022 | ₹2.64 Cr | 184.90 | |
| Mar2021 | ₹0.93 Cr | - | |
Compare Contingent Liabilities of peers of MOREPEN LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MOREPEN LABORATORIES | ₹2,201.3 Cr | 13.1% | -6.2% | -19.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,150.0 Cr | -2.2% | -1.8% | -2.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹156,129.0 Cr | -1.6% | -7.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,312.0 Cr | -4.1% | -6.7% | 23.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,445.2 Cr | -4.7% | -7.3% | 6.4% | Stock Analytics | |
| CIPLA | ₹98,210.2 Cr | -1.7% | -8.4% | -16.7% | Stock Analytics | |
MOREPEN LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MOREPEN LABORATORIES | 13.1% |
-6.2% |
-19.6% |
| SENSEX | 7.8% |
-2% |
0.2% |
You may also like the below Video Courses